Recent Quotes
"MDT has 25–35% share in markets with all its stent products launched."
—
Adam Feinstein, Barclays
(3/19/12)
more >
Due to permission requirements, not all quotes are shown.
Why this seasoned money manager sees real upside for this innovative B2B tech startup. on 10/26/2021. Learn More
© 2021 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
